These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33044013)

  • 1. Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study.
    Bergsland N; Benedict RHB; Dwyer MG; Fuchs TA; Jakimovski D; Schweser F; Tavazzi E; Weinstock-Guttman B; Zivadinov R
    J Magn Reson Imaging; 2021 Mar; 53(3):731-739. PubMed ID: 33044013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal subfields and thalamic nuclei associations with clinical outcomes in multiple sclerosis: An ultrahigh field MRI study.
    Santini T; Chen C; Zhu W; Liou JJ; Walker E; Venkatesh S; Farhat N; Sajewski A; Alkhateeb S; Saranathan M; Xia Z; Ibrahim TS
    Mult Scler Relat Disord; 2024 Jun; 86():105520. PubMed ID: 38582026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamic nuclei degeneration in multiple sclerosis.
    Trufanov A; Bisaga G; Skulyabin D; Temniy A; Poplyak M; Chakchir O; Efimtsev A; Dmitriy T; Odinak M; Litvinenko I
    J Clin Neurosci; 2021 Jul; 89():375-380. PubMed ID: 34090763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
    Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
    J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of thalamic nuclei atrophy in early relapse-onset multiple sclerosis.
    Levy S; Sandry J; Beck ES; Brandstadter R; Katz Sand I; Sumowski JF
    Mult Scler Relat Disord; 2022 Nov; 67():104083. PubMed ID: 35940020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
    Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
    J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
    de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
    Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia study.
    Shah SN; Dounavi ME; Malhotra PA; Lawlor B; Naci L; Koychev I; Ritchie CW; Ritchie K; O'Brien JT
    Brain Commun; 2024; 6(2):fcae046. PubMed ID: 38444908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential vulnerability of thalamic nuclei in multiple sclerosis.
    Blyau S; Koubiyr I; Saranathan M; Coupé P; Deloire M; Charré-Morin J; Saubusse A; Zhang B; Rutt B; Dousset V; Brochet B; Ruet A; Tourdias T
    Mult Scler; 2023 Feb; 29(2):295-300. PubMed ID: 35959722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E; Petsas N; Tona F; Prosperini L; Raz E; Pace G; Pozzilli C; Pantano P
    PLoS One; 2013; 8(5):e63250. PubMed ID: 23696802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial for "Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study".
    Lui EH
    J Magn Reson Imaging; 2021 Mar; 53(3):740-741. PubMed ID: 33103820
    [No Abstract]   [Full Text] [Related]  

  • 17. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
    D'hooghe MB; Gielen J; Van Remoortel A; D'haeseleer M; Peeters E; Cambron M; De Keyser J; Nagels G
    J Magn Reson Imaging; 2019 May; 49(5):1312-1321. PubMed ID: 30597656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.